Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,389
datasets available to search
ShareScore release 0.9.0
Dataset results
1,389 results for “Bladder cancer”
Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy
ClinicalTrials.gov study NCT02355886. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT06929286. IPD Sharing: YES. Countries: 1. Publications: 0.
Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT07180212. IPD Sharing: NO. Countries: 1. Publications: 0.
Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer
ClinicalTrials.gov study NCT04323722. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TURBt With Adjuvant Cryoablation to Treat Bladder Cancer
ClinicalTrials.gov study NCT02760953. IPD Sharing: UNDECIDED. Countries: 0. Publications: 3.
AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT04430036. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer
ClinicalTrials.gov study NCT04917809. IPD Sharing: YES. Countries: 1. Publications: 0.
Pembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT03167151. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT01916109. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer
ClinicalTrials.gov study NCT04039867. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Metadherin mRNA Expression in Bladder Cancer
ClinicalTrials.gov study NCT04286672. IPD Sharing: NO. Countries: 0. Publications: 12.
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
ClinicalTrials.gov study NCT03258593. IPD Sharing: YES. Countries: 1. Publications: 0.
Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
ClinicalTrials.gov study NCT02300610. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG
ClinicalTrials.gov study NCT02449239. IPD Sharing: NO. Countries: 2. Publications: 0.
Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Platinum Resistant Urothelial Bladder Cancer
ClinicalTrials.gov study NCT02351739. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment
ClinicalTrials.gov study NCT06537154. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer
ClinicalTrials.gov study NCT02560038. IPD Sharing: NO. Countries: 1. Publications: 0.
Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder Cancer
ClinicalTrials.gov study NCT01126749. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
ClinicalTrials.gov study NCT05126472. IPD Sharing: YES. Countries: 1. Publications: 0.
Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT00847015. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.